 Deciphera Pharmaceuticals Inc NASDAQ: DCPH announced four e-poster presentations at the European Society for Medical Oncology ESMO21 Virtual Conference 2021. The presentations include updated preliminary results from the ongoing Phase 1b2 study of rebastinib plus paclitaxel in Platinum-Resistant Ovarian Cancer PROC and vimseltinib in patients with Tenosynovial Giant Cell Tumor TGCT. 